433 results
8-K
EX-99.2
LSTA
Lisata Therapeutics Inc
9 May 24
Lisata Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
4:08pm
and Rolling Review Certepetide received Fast Track Designation from FDA for pancreatic cancer Orphan Drug Designation Incentives such as tax
8-K
EX-99.2
h11uz2erk1e7rvg7g
29 Feb 24
Lisata Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update
4:09pm
8-K
EX-99.2
2ig4no
2 Nov 23
Lisata Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update
4:10pm
8-K
EX-99.1
jsnov9kj2j9f18wk
14 Aug 23
Lisata Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Update
4:08pm
8-K
EX-99.1
x8jf6rj5stf52c ues7
9 May 23
Lisata Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Update
4:08pm